116 related articles for article (PubMed ID: 37565616)
41. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics and Macrophage Inhibitory Cytokine-1 Pharmacodynamics of the Murine Double Minute 2 Inhibitor, Navtemadlin (KRT-232) in Fed and Fasted Healthy Subjects.
Wong S; Krejsa C; Lee D; Harris A; Simard E; Wang X; Allard M; Podoll T; O'Reilly T; Slatter JG
Clin Pharmacol Drug Dev; 2022 May; 11(5):640-653. PubMed ID: 35172043
[TBL] [Abstract][Full Text] [Related]
43. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
44. Effect of Food Intake and Body Position on the Pharmacokinetics of Swallowed APT-1011, a Fluticasone Orally Disintegrating Tablet, in Healthy Adult Volunteers.
Comer GM; Bush MA; Dellon ES; Marino MT
J Clin Pharmacol; 2020 Jun; 60(6):734-743. PubMed ID: 31943257
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects.
Li S; Xu M; Li H; Du J; Li W
Adv Ther; 2016 Oct; 33(10):1704-1714. PubMed ID: 27444313
[TBL] [Abstract][Full Text] [Related]
46. Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors.
Nemunaitis J; Young A; Ejadi S; Miller W; Chen LC; Nichols G; Blotner S; Vazvaei F; Zhi J; Razak A
Cancer Chemother Pharmacol; 2018 Mar; 81(3):529-537. PubMed ID: 29368050
[TBL] [Abstract][Full Text] [Related]
47. Clinical development of an everolimus pediatric formulation: relative bioavailability, food effect, and steady-state pharmacokinetics.
Kovarik JM; Noe A; Berthier S; McMahon L; Langholff WK; Marion AS; Hoyer PF; Ettenger R; Rordorf C
J Clin Pharmacol; 2003 Feb; 43(2):141-7. PubMed ID: 12616666
[TBL] [Abstract][Full Text] [Related]
48. Effects of Differential Food Patterns on the Pharmacokinetics of Enteric-Coated Mesalazine Tablets in the Same Cohort of Healthy Chinese Volunteers.
Zhang SH; Li Y; Wei SS; Guo L; Huang XM; Chen Y; Wu XX; Cai HL; Zhang BK
Clin Pharmacol Drug Dev; 2020 Jan; 9(1):41-49. PubMed ID: 31056855
[TBL] [Abstract][Full Text] [Related]
49. Effect of food on the single-dose pharmacokinetics and tolerability of savolitinib in Chinese healthy volunteers.
Ding Q; Ou M; Zhu H; Wang Y; Jia J; Sai Y; Chen Q; Wang J
Fundam Clin Pharmacol; 2022 Feb; 36(1):210-217. PubMed ID: 34022080
[TBL] [Abstract][Full Text] [Related]
50. A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers.
Xiao F; Zhang F; Zhang LL; Wei W
Eur J Clin Pharmacol; 2018 Jan; 74(1):69-77. PubMed ID: 29051989
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetic characteristics of golidocitinib, a highly selective JAK1 inhibitor, in healthy adult participants.
Chen K; Guan X; Yang Z; Zhou Y; Liu Z; Deng X; Liu D; Hu P; Chen R
Front Immunol; 2023; 14():1127935. PubMed ID: 37077916
[TBL] [Abstract][Full Text] [Related]
52. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
[TBL] [Abstract][Full Text] [Related]
53. A randomized, open-label, 5-period, balanced crossover study to evaluate the relative bioavailability of eltrombopag powder for oral suspension (PfOS) and tablet formulations and the effect of a high-calcium meal on eltrombopag pharmacokinetics when administered with or 2 hours before or after PfOS.
Wire MB; Bruce J; Gauvin J; Pendry CJ; McGuire S; Qian Y; Brainsky A
Clin Ther; 2012 Mar; 34(3):699-709. PubMed ID: 22336488
[TBL] [Abstract][Full Text] [Related]
54. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
[TBL] [Abstract][Full Text] [Related]
55. Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tablet
.
Scheidel B; Maritz MA; Gschwind YJ; Steigerwald K; Guth V; Kovacs P; Rey H
Int J Clin Pharmacol Ther; 2017 Nov; 55(11):881-890. PubMed ID: 28933336
[TBL] [Abstract][Full Text] [Related]
56. Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator.
Trivedi A; Oberoi RK; Mackowski M; Jafarinasabian P; Zhang H; Flach S; Simiens MA; Terminello B; Abbasi S; Dutta S; Lee E
Biopharm Drug Dispos; 2021 Jul; 42(7):319-328. PubMed ID: 34087948
[TBL] [Abstract][Full Text] [Related]
57. Food effects on the pharmacokinetics of doxylamine hydrogen succinate 25 mg film-coated tablets: a single-dose, randomized, two-period crossover study in healthy volunteers.
Videla S; Lahjou M; Guibord P; Xu Z; Tolrà C; Encina G; Sicard E; Sans A
Drugs R D; 2012 Dec; 12(4):217-25. PubMed ID: 23230999
[TBL] [Abstract][Full Text] [Related]
58. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
[TBL] [Abstract][Full Text] [Related]
60. Relative bioavailability of a pediatric dispersible tablet and adult film-coated tablet of macitentan in healthy volunteers.
Sidharta PN; Štěpánová R; Globig S; Ulč I; Csonka D
Pharmacol Res Perspect; 2020 Apr; 8(2):e00580. PubMed ID: 32302056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
